This exploratory grant proposal is focused on investigating the functional relevance of Fra-1 protooncogene in lung tumor initiation and progression promoted by cigarette smoke carcinogens in vivo. Fra-1 is a dimeric partner of AP-1 transcription factor and regulates gene expression implicated in both normal and pathologic processes. Emerging data obtained from cell culture based studies have unequivocally demonstrated a causative role for Fra-1 in various cancer cell progression and invasion. We have shown that Fra-1 is strongly activated in lung epithelial cells by cigarette smoke, a major determinant of lung cancer, as well as tumor promoting mitogenic and pro-inflammatory stimuli. We have demonstrated that overexpression of Fra-1 promotes lung epithelial cell motility and invasion in vitro, but it requires other activated protooncogene(s) to impart its oncogenic potential in vivo in immunocompromised mice. Our preliminary results suggests that a matrix mettalloproteinase (MMP) mediated EGFR-activated Ras-ERK pathway is crucial for cigarette smoke induced Fra-1 expression. This pathway is also critical for Fra-1 induced lung epithelial cell motility and invasion. Based on these preliminary observations, we hypothesize that Fra-1is a critical determinant of lung tumorogenesis and progression in vivo and this transcription factor may provide a good target for lung cancer therapy. To test this hypothesis, we will determine whether Fra-1 protoconogene is a critical mediator of oncogenic K-Ras-induced lung tumor initiation and development in vivo (Specific Aim 1). In complimentary studies, we will investigate whether a targeted disruption of Fra-1 in lung epithelium inhibits lung tumor initiation and progression promoted by cigarette smoke carcinogens in vivo (Specific Aim 2). Conventional deletion of Fra-1 results in embryonic lethality. Thus, we will examine for the first time the specific roles of Fra-1 in lung neoplasms using mice with a Fra-1 """"""""floxed"""""""" allele to conditionally delete Fra- 1 in lung cell types. The proposed studies are not only novel in terms of elucidating the biology and functions of Fra-1 but will also provide critical insights into the mechanistic basis underlying toxicant-induced lung tumor development. As protooncogenic transcription factors control expression of genes that promote lung tumor initiation and growth, these results could enable us to target Fra-1, or steps that specifically regulate Fra-1, as novel therapeutic agent(s) against cigarette smoke-induced lung neoplasms in subsequent studies.

Public Health Relevance

Lung tumor initiation and progression involves molecular changes such as silencing of tumor suppressor genes and deregulation of proto-oncogene expression and/or activation that promote cell growth and transformation leading to tumor development. Thus, specifically targeting the effector proto-oncogenic transcription factors activated by toxicants that promote lung tumor initiation, growth and/or maintenance may provide new therapeutic opportunities to develop novel treatment strategies for the prevention and/or treatment of second hand tobacco smoke -induced lung neoplasms.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Nadadur, Srikanth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois at Chicago
Schools of Medicine
United States
Zip Code
Elangovan, Indira M; Vaz, Michelle; Tamatam, Chandramohan R et al. (2018) FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation. Am J Respir Cell Mol Biol 58:625-635
Rajasekaran, Subbiah; Tamatam, Chandramohan R; Potteti, Haranatha R et al. (2015) Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging. Am J Physiol Lung Cell Mol Physiol 309:L414-24
Reddy, Sekhar P; Natarajan, Viswanathan; Dudek, Arkadiusz Z (2014) MARCKS is marked in combating lung cancer growth and acquired resistance. Am J Respir Crit Care Med 190:1084-6
Rajasekaran, Subbiah; Reddy, Narsa M; Zhang, Wei et al. (2013) Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis. BMC Genomics 14:381
Potteti, Haranatha R; Reddy, Narsa M; Hei, Tom K et al. (2013) The NRF2 activation and antioxidative response are not impaired overall during hyperoxia-induced lung epithelial cell death. Oxid Med Cell Longev 2013:798401
Yusuf, Dimas; Butland, Stefanie L; Swanson, Magdalena I et al. (2012) The transcription factor encyclopedia. Genome Biol 13:R24
Rajasekaran, Subbiah; Vaz, Michelle; Reddy, Sekhar P (2012) Fra-1/AP-1 transcription factor negatively regulates pulmonary fibrosis in vivo. PLoS One 7:e41611